'Game-changing' nasal spray COVID-19 vaccine under investigation in Australia
A team of Australian scientists is researching whether the COVID-19 vaccine could be delivered via a nasal spray instead of injection.
The nasal spray technology, called NanoCelle, does not require a doctor or refrigeration before it is administered.
If successful it would ease demand being placed on GPs and pharmacists amid the vaccine rollout.
READ MORE: Can you get long COVID-19 after an Omicron infection?
A nasal spray COVID-19 vaccine is under investigation in NSW. Getty
Medlab Clinical obtained a New South Wales Government grant for developing a proof-of-concept NanoCelle Nasal RNA vaccine in January. They will work in partnership with the University of NSW and Macquarie University.
Medlab CEO Dr Sean Hall said the potential vaccine is a "game-changer" and hopes it can be used for COVID-19 potential epidemics in future.
LIVE UPDATES: Tourism operator 'nearly in tears' over possible vaccine mandate
The spray wouldn't need a doctor to administer it, easing pressure on vaccine hubs, AP
"The ability to prove the efficacious delivery of vaccines without the 'jab' is a serious game-changer to modern medicine," he said.
"We are thrilled to be part of this and welcome the potential commercial opportunities ahead."
Patented by the company in 43 nations, NanoCelle is a sub-micron delivery platform leveraged to improve therapeutics.
READ MORE: Therapeutic Goods Administration approves AstraZeneca for booster shots
Nation-wide 93.8 per cent of people aged 16 and over have had their second dose, while 9,371,322 people over the age of 16 have received more than two doses.
Share a tip-off, video or photo with us
